Skip to main content
S 288 117th Congress Senate Health Advisory bodies Blood and blood diseases Cell biology and embryology Congressional oversight Government studies and investigations Health programs administration and funding Medical research Organ and tissue donation and transplantation Research administration and funding

TRANSPLANT Act of 2021

Introduced: February 8, 2021 Introduced by: Reed, Jack Democratic · Rhode Island See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 8, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)
Feb 8, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2021 or the TRANSPLANT Act of 2021

This bill modifies and reauthorizes through FY2026 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant.

The bill also requires the Department of Health and Human Services to conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments.

In addition, the Government Accountability Office must report on the regenerative medicine workforce.

What's happening now February 8, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S575)

 Committees of jurisdiction 1
 Cosponsors 3
All 3 Democratic 2 Republican 1